Issue 43 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

37

No.

43

November 18, 2011Nov 18, 2011

Free

DOWNLOAD THE PDF

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

Industry Groups Lobby for Lower Standards for FDA Approval

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026